Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPTImal Treatment of Sinus VENOSUS Defect - Efficacy and Safety of Transcatheter Correction Compared to Surgical Treatment in Patients With Sinus Venosus Defect

NCT05865119 is registered in ClinicalTrials.gov with Centre Chirurgical Marie Lannelongue as lead sponsor.

NCT NCT05865119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05865119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPTImal Treatment of Sinus VENOSUS Defect - Efficacy and Safety of Transcatheter Correction Compared to Surgical Treatment in Patients With Sinus Venosus Defect
Lead sponsor
Centre Chirurgical Marie Lannelongue
Phase
Not applicable
Overall status
Recruiting
Start date
May 12, 2023
Completion date
May 12, 2029
Enrollment
60 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease, sinus venosus atrial septum defect, sinus venosus defect